Addressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts Attention

Source: EClinCloud. Author: EClinCloud.
From November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver the “Practice and Application of AI in Clinical Research” keynote speech, sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests.



01
Current Landscape of AI-Enabled New Drug R&D
AI is demonstrating application value in multiple stages of new drug R&D, covering preclinical phases such as target discovery, molecular design, and virtual screening, as well as the clinical trial phase.
Compared to the preclinical stage, clinical trials involve more complex organizational collaboration and data management, and face challenges in massive data processing, multi-center collaboration, compliance management, and high monitoring and operational costs.
Clinical research involves multi-center collaboration and massive data management, not only facing issues such as error-prone manual processing, difficulty in data traceability, and high operational collaboration costs, but also requiring compliance with strict regulations such as GCP, 21 CFR Part 11, and others. At the same time, limited resources also make it difficult to detect problems during the research process in a timely manner.
To address these challenges, the speech introduced the main directions of AI intervention in clinical research: intelligent protocol design, intelligent patient matching, automatic EDC database setup, remote intelligent monitoring, and risk prediction, exploring how AI can improve the efficiency and quality of clinical research design, execution, and management.
02
EClinCloud Reshapes Clinical Research with AI
Addressing the practical needs of clinical research, EClinCloud is driven by AI technological innovation, relying on its integrated clinical intelligence platform to incorporate AI capabilities into multiple business segments of clinical research, promoting the implementation of applications such as intelligent database setup, data collection, risk monitoring, document management, and data analysis.
In EClinCloud's AI applications, the value of AI lies not just in replacing a single manual operation, but more importantly in connecting dispersed business segments, making data processing, project management, and research collaboration more efficient, offloading repetitive work to machines, and returning time to professional judgment.
Furthermore, relying on the strategic cooperation with Tencent Cloud, EClinCloud has introduced WorkBuddy to further explore the application of AI agents in the daily work of clinical research. Both parties will focus on the actual business needs of pharmaceutical companies to jointly build AI workflows, conduct training on the use of agents, and promote the accumulation and reuse of corporate knowledge assets such as SOPs and project experience.
From assisting business operations to supporting research management and team collaboration, the integration of AI and clinical research is deepening. EClinCloud will also continue to explore the combination of AI technology and clinical research scenarios, using technological innovation to promote quality and efficiency in clinical research.
EClinCloud is a leading AI company in the clinical research industry, which leverages AI-driven technology to build an integrated clinical intelligence cloud platform and endpoint assessment technology. It provides global pharmaceutical companies and research institutions with technology products such as eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as services for scale management, linguistic validation, rater training, and data quality analysis. By building efficient and precise digital solutions, and relying on AI predictive models and an intelligent data platform, it dynamically evaluates and helps improve the success rate of drug clinical trials, aiming to shorten the R&D cycle of drugs/medical devices and benefit patients.



